Clinical Trial Update: Trial of Myocet in Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial of Myocet in metastatic breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Myocet (liposomal doxorubicin)

Snippet

Sponsor: Sopherion Therapeutics | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN